| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60505-3631-3 | 60505-3631 | HUMAN PRESCRIPTION DRUG | Dasatinib | Dasatinib | TABLET, FILM COATED | ORAL | 20240903 | N/A | ANDA | ANDA202103 | Apotex Corp. | DASATINIB | 100 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3631-3) |
| 60505-3628-6 | 60505-3628 | HUMAN PRESCRIPTION DRUG | Dasatinib | Dasatinib | TABLET, FILM COATED | ORAL | 20240903 | N/A | ANDA | ANDA202103 | Apotex Corp. | DASATINIB | 20 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3628-6) |
| 60505-3629-6 | 60505-3629 | HUMAN PRESCRIPTION DRUG | Dasatinib | Dasatinib | TABLET, FILM COATED | ORAL | 20240903 | N/A | ANDA | ANDA202103 | Apotex Corp. | DASATINIB | 50 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3629-6) |
| 60505-3630-6 | 60505-3630 | HUMAN PRESCRIPTION DRUG | Dasatinib | Dasatinib | TABLET, FILM COATED | ORAL | 20240903 | N/A | ANDA | ANDA202103 | Apotex Corp. | DASATINIB | 70 mg/1 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3630-6) |